Prostatype Genomics AB - ESG Rating & Company Profile powered by AI
The assessment of Prostatype Genomics AB is assembled by All Street Sevva using proprietary artificial intelligence. Detailed Sustainability analysis of Prostatype Genomics AB are accessed by signing up for free. The analysis of Prostatype Genomics AB incorporates data from across the web and also from available filings by Prostatype Genomics AB.
Prostatype Genomics AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Prostatype Genomics AB | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Prostatype Genomics AB have an accelerator or VC vehicle to help deliver innovation?
Does Prostatype Genomics AB disclose current and historical energy intensity?
Does Prostatype Genomics AB report the average age of the workforce?
Does Prostatype Genomics AB reference operational or capital allocation in relation to climate change?
Does Prostatype Genomics AB disclose its ethnicity pay gap?
Does Prostatype Genomics AB disclose cybersecurity risks?
Does Prostatype Genomics AB offer flexible work?
Does Prostatype Genomics AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Prostatype Genomics AB disclose the number of employees in R&D functions?
Does Prostatype Genomics AB conduct supply chain audits?
Does Prostatype Genomics AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Prostatype Genomics AB conduct 360 degree staff reviews?
Does Prostatype Genomics AB disclose the individual responsible for D&I?
Does Prostatype Genomics AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Prostatype Genomics AB disclose current and / or historical scope 2 emissions?
Does Prostatype Genomics AB disclose water use targets?
Does Prostatype Genomics AB have careers partnerships with academic institutions?
Did Prostatype Genomics AB have a product recall in the last two years?
Does Prostatype Genomics AB disclose incidents of discrimination?
Does Prostatype Genomics AB allow for Work Councils/Collective Agreements to be formed?
Has Prostatype Genomics AB issued a profit warning in the past 24 months?
Does Prostatype Genomics AB disclose parental leave metrics?
Does Prostatype Genomics AB disclose climate scenario or pathway analysis?
Does Prostatype Genomics AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Prostatype Genomics AB disclose the pay ratio of women to men?
Does Prostatype Genomics AB support suppliers with sustainability related research and development?
Does Prostatype Genomics AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Prostatype Genomics AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Prostatype Genomics AB involved in embryonic stem cell research?
Does Prostatype Genomics AB disclose GHG and Air Emissions intensity?
Does Prostatype Genomics AB disclose its waste policy?
Does Prostatype Genomics AB report according to TCFD requirements?
Does Prostatype Genomics AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Prostatype Genomics AB disclose energy use targets?
Does Prostatype Genomics AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Prostatype Genomics AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Prostatype Genomics AB
These potential risks are based on the size, segment and geographies of the company.
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The test is based on database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision. The company was founded in 2007 and is based in Solna, Sweden.